Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
2.
Hepatobiliary Pancreat Dis Int ; 9(1): 103-6, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20133240

ABSTRACT

BACKGROUND: Acinar cell carcinoma (ACC) is a rare malignancy of the pancreas arising from acinar cells. Unlike ductal adenocarcinoma, this tumor rarely presents with pancreatitis. METHODS: We present a case of ACC associated with chronic calcifying pancreatitis, and a review of the literature focusing on diagnosis and management. RESULTS: A 43-year-old man was proposed for Wirsungojejunal derivation for chronic pancreatitis. Histopathological examination of the tissue extracted revealed an ACC. Duodenopancreatectomy was performed. Six months post-operatively, the patient developed hepatic metastasis and was treated with gemcitabine as palliative chemotherapy. CONCLUSIONS: The clinical presentation of ACC of the pancreas is not specific and the tumor can be under-diagnosed when associated with chronic pancreatitis. Data regarding course, treatment, and prognosis of this tumor are generally lacking.


Subject(s)
Carcinoma, Acinar Cell/diagnosis , Pancreatic Neoplasms/diagnosis , Pancreatitis, Chronic/complications , Adult , Carcinoma, Acinar Cell/surgery , Humans , Male , Pancreatic Neoplasms/surgery , Prognosis
3.
Tunis Med ; 87(2): 133-6, 2009 Feb.
Article in French | MEDLINE | ID: mdl-19522447

ABSTRACT

AIM: The aim of this study is to review clinical data, histological and immunohistochemical findings and prognosis of stromal gastrointestinal tumors. METHODS: A retrospective Study of 32 cases of stromal gastrointestinal tumors diagnosed in the Department of Pathology of Mongi Slim Hospital of Tunis from 1991 to 2004. RESULTS: The average age of the patients was of 54.4 years, equal for sex. Tumors were essentially gastric (50%) and of the small intestine (37.5%). All the patients had surgical treatment. Gastro-intestinal Stromal Tumors or GIST represent the most frequent stromal tumor with 56.2% of cases. CONCLUSION: After immunohistochimestry study, using CD117 antigen, this revision allows better management of GIST. Glivec is the standard treatment of advanced GIST.


Subject(s)
Biomarkers, Tumor/metabolism , Duodenal Neoplasms/metabolism , Gastrointestinal Stromal Tumors/metabolism , Ileal Neoplasms/metabolism , Jejunal Neoplasms/metabolism , Proto-Oncogene Proteins c-kit/metabolism , Stomach Neoplasms/metabolism , Adult , Aged , Aged, 80 and over , Antineoplastic Agents/therapeutic use , Benzamides , Duodenal Neoplasms/diagnosis , Duodenal Neoplasms/drug therapy , Duodenal Neoplasms/surgery , Female , Gastrointestinal Stromal Tumors/diagnosis , Gastrointestinal Stromal Tumors/drug therapy , Gastrointestinal Stromal Tumors/surgery , Humans , Ileal Neoplasms/diagnosis , Ileal Neoplasms/drug therapy , Ileal Neoplasms/surgery , Imatinib Mesylate , Jejunal Neoplasms/diagnosis , Jejunal Neoplasms/drug therapy , Jejunal Neoplasms/surgery , Male , Middle Aged , Piperazines/therapeutic use , Pyrimidines/therapeutic use , Retrospective Studies , Stomach Neoplasms/diagnosis , Stomach Neoplasms/drug therapy , Stomach Neoplasms/surgery , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...